Antineoplastic drugs doxorubicin and daunorubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured HL-60 Cells K562 Cells Lymphocytes Heart Vault Ribonucleoprotein Particles Cell Line

Organisms2

Streptomyces Mice, Nude

Diseases16

Leukemia, Prolymphocytic, B-Cell Breast Neoplasms Leukemia P388 Neoplasms Leukemia, Myeloid, Acute Carcinoma, Ehrlich Tumor Leukemia, Myeloid Leukemia L1210 Leukemia Leukemia, Experimental Lung Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Heart Diseases Neutropenia Lymphoma, Non-Hodgkin Acute Disease

Chemicals and Drugs57

Daunorubicin Doxorubicin Antibiotics, Antineoplastic Antineoplastic Agents Drug Carriers Cytarabine Naphthacenes Cyclophosphamide P-Glycoprotein Antineoplastic Agents, Phytogenic Cisplatin Antineoplastic Agents, Alkylating Hazardous Substances Etoposide Razoxane Vincristine Paclitaxel Idarubicin Anthracyclines Verapamil Liposomes Fluorouracil Mitoxantrone Aclarubicin Cyclosporins Thioguanine Enzyme Inhibitors Vinblastine Methotrexate Multidrug Resistance-Associated Proteins Prednisone Antimetabolites, Antineoplastic RNA, Messenger Topoisomerase II Inhibitors Rhodamine 123 6-Mercaptopurine Anthraquinones DNA Topoisomerases, Type II Asparaginase Amsacrine Bleomycin Benzylisoquinolines Ellipticines Pyrazolones Polyethylene Glycols Ifosfamide ATP-Binding Cassette Transporters Prodrugs Vault Ribonucleoprotein Particles Neoplasm Proteins Phospholipid Ethers Gallium Bryostatins Thiadiazines Epirubicin Cardiotoxins Hydroxyethylrutoside

Analytical, Diagnostic and Therapeutic Techniques and Equipment27

Drug Carriers Gloves, Protective Drug Delivery Systems Equipment and Supplies, Hospital Protective Clothing Protective Devices Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Drug Compounding Comet Assay Mutagenicity Tests Remission Induction Drug Administration Schedule Treatment Outcome Survival Analysis Leukemia, Experimental Infusions, Intravenous Inhibitory Concentration 50 Combined Modality Therapy Disease-Free Survival Xenograft Model Antitumor Assays Consolidation Chemotherapy Tumor Stem Cell Assay Neoplasm Transplantation Flow Cytometry Survival Rate Drug Evaluation

Phenomena and Processes17

Drug Resistance, Neoplasm Cell Survival Apoptosis Drug Resistance, Multiple Drug Synergism DNA Damage Dose-Response Relationship, Drug Drug Resistance Genes, MDR Drug Interactions Inhibitory Concentration 50 Cell Division Time Factors Cell Proliferation Drug Agonism Kinetics Molecular Structure

Disciplines and Occupations1

Veterinary Medicine

Technology, Industry, Agriculture6

Gloves, Protective Laundering Protective Clothing Protective Devices Liposomes Polyethylene Glycols

Information Science1

Named Groups5

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital Nurses Pharmacists

Health Care15

Medical Secretaries Occupational Exposure Equipment Contamination Nursing Staff, Hospital Environmental Monitoring Personnel, Hospital Pharmacies Nurses Pharmacists Hospitals Safety Management Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate

Geographicals2

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Daunorubicin Doxorubicin Antibiotics, Antineoplastic Antineoplastic Agents Leukemia, Prolymphocytic, B-Cell Drug Carriers Cell Line, Tumor Drug Resistance, Neoplasm Gloves, Protective Drug Delivery Systems Cell Survival Medical Secretaries Apoptosis Cytarabine Laundering Tumor Cells, Cultured Occupational Exposure Equipment and Supplies, Hospital Protective Clothing Protective Devices Drug Resistance, Multiple Equipment Contamination Naphthacenes Nursing Staff, Hospital Breast Neoplasms Cyclophosphamide Environmental Monitoring Personnel, Hospital P-Glycoprotein Pharmacies Antineoplastic Agents, Phytogenic Cisplatin Antineoplastic Agents, Alkylating Drug Screening Assays, Antitumor Hazardous Substances Antineoplastic Combined Chemotherapy Protocols Etoposide Leukemia P388 Razoxane Drug Compounding Vincristine Nurses Comet Assay Paclitaxel Pharmacists Idarubicin Anthracyclines Drug Synergism DNA Damage Neoplasms Hospitals Dose-Response Relationship, Drug Drug Resistance Mutagenicity Tests Veterinary Medicine Verapamil Liposomes Fluorouracil Leukemia, Myeloid, Acute Mitoxantrone Aclarubicin Carcinoma, Ehrlich Tumor Cyclosporins Remission Induction Thioguanine Drug Administration Schedule HL-60 Cells Leukemia, Myeloid Italy Japan Safety Management Enzyme Inhibitors Vinblastine Methotrexate Multidrug Resistance-Associated Proteins Streptomyces Leukemia L1210 Prednisone Treatment Outcome Antimetabolites, Antineoplastic RNA, Messenger Genes, MDR K562 Cells Topoisomerase II Inhibitors Lymphocytes Rhodamine 123 6-Mercaptopurine Anthraquinones DNA Topoisomerases, Type II Asparaginase Drug Interactions Survival Analysis Leukemia Amsacrine Leukemia, Experimental Infusions, Intravenous Bleomycin Inhibitory Concentration 50 Cell Division Combined Modality Therapy

No FAQ available that match "antineoplastic drugs doxorubicin and daunorubicin"